Preterm Labor : Evidence Based View

61
Preterm Labor: Evidence Based View

description

Preterm Labor : Evidence Based View. Evidence Based Sources:. PubMed Cochrean library RCOG Guidelines ACOG Issues Guidelines National Guideline Clearinghouse MOH Sing. Guideline. Definition. - PowerPoint PPT Presentation

Transcript of Preterm Labor : Evidence Based View

Page 1: Preterm Labor : Evidence Based View

Preterm Labor:Evidence Based View

Page 2: Preterm Labor : Evidence Based View

Evidence Based Sources:

PubMedCochrean libraryRCOG GuidelinesACOG Issues GuidelinesNational Guideline ClearinghouseMOH Sing. Guideline

Page 3: Preterm Labor : Evidence Based View

Definition

Preterm labor is the presence of contractions of sufficient strength and frequency to effect progressive effacement and dilation of the cervix between 20 and 37 weeks' gestation

WHO

Page 4: Preterm Labor : Evidence Based View

Preterm Labor

Incidence : 6- 10%

• Spontaneous : 40-50%

• PROM : 25-40%

• Obstetrically indicated : 20-25%

Page 5: Preterm Labor : Evidence Based View

Preterm Labor Most mortality and

morbidity is experienced

by babies born before 34

weeks.

Page 6: Preterm Labor : Evidence Based View

Major Risks Of Preterm Delivery• Death • Respiratory distress syndrome • Hypothermia • Hypoglycaemia • Necrotising enterocolitis • Jaundice • Infection • Retinopathy of prematurity

Goldenberg , Obstetrics &Gynecology 11-2002

Page 7: Preterm Labor : Evidence Based View

Can preterm labor be predicted?

Page 8: Preterm Labor : Evidence Based View

Prediction1. Assessment of risk factors 2. Vaginal examination to assess the

cervical status 3. Ultrasound visualization of

cervical length and dilatation 4. Detection of foetal fibronectin in

cervicovaginal secretions

Page 9: Preterm Labor : Evidence Based View

1-Risk Factors While the exact cause of

preterm labor is often unknown, there is strong evidence that intrauterine infection may play a role in very early preterm labor.

ACOG NEWS RELEASE November 2002

Page 10: Preterm Labor : Evidence Based View

Bacterial Vaginosis Bacterial vaginosis increased the

risk of preterm delivery >2-fold .

Leitich et al Am J Obstet Gynecol. 2003 Jul;189(1):139 ( Meta-Analysis)

1-Risk Factors

Page 11: Preterm Labor : Evidence Based View

Multiple pregnancy: risk >50%Previous preterm delivery: risk 20- 40%Cigarette smoking: risk 20-30%Cervical incompetence Uterine abnormalities

MOH Sing. Guideline Grade C Recommendation 2001

Other Risk Factors1-Risk Factors

Page 12: Preterm Labor : Evidence Based View

Young age of mother - less than 16 years of age.•Lower socioeconomic class.Reduced body mass index (BMI) - BMI less than 19.0.Antiphosphlipid syndrome. Obstetric complications, including hypertension in pregnancy,antepartum haemorrhage, infection, polyhydramnios, foetalabnormalities.

MOH Sing. Guideline Grade C Recommendation 2001

Other Risk Factors1-Risk Factors

Page 13: Preterm Labor : Evidence Based View

2-Vaginal examination

Digital examination is the traditional method used to detect cervical maturation, but quantifying these changes is often difficult.

Page 14: Preterm Labor : Evidence Based View

3-Vaginal U/SVaginal ultrasonography

allows a more objective approach to examination of the cervix.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 15: Preterm Labor : Evidence Based View

Outcome Sensitivity specificity

Delivery <37

Delivery <34

52%

53%

85%

89%

Delivery within 1 Week

Delivery within 2 Week

Delivery within 3 Week

Leitich & Kaider ,BJOG. 2003 Apr;110 , 20:66-70. Meta-Analysis 40 studies

71%

67%

59% 92%

89%

89%

4-Fibronectin Test

Page 16: Preterm Labor : Evidence Based View

Prevention

Page 17: Preterm Labor : Evidence Based View

Prevention of Preterm Labor

Women at increased risk of preterm delivery may be identified by various risk factors in the obstetric history and treated.

American Academy of Pediatrician & ACOG 1997

Page 18: Preterm Labor : Evidence Based View

17 Hydroxy -Progesterone Caproate

Prophylactic use of 17 hydroxy progesterone caproate to prevent preterm labor revealed a significant decrease in preterm birth .

However, it has not successfully inhibited active preterm labor.

Meis et al. N Engl J Med. 2003 Jun 12;348(24):2379-85.RCT (19 centers )

Keirse. Br J Obstet Gynaecol 1990;97:149-54. Meta-anlysis of 6RCTs.

Page 19: Preterm Labor : Evidence Based View

Treatment Of Vaginosis Treatment of asymptomatic abnormal

vaginal flora and bacterial vaginosis with oral clindamycin early in the 2nd trimester significantly reduces the rate of late miscarriage and spontaneous preterm birth.

Ugwumadu et al. Lancet. 2003 Mar 22;361:983-8. ) RCT

Page 20: Preterm Labor : Evidence Based View

Diagnosis

Page 21: Preterm Labor : Evidence Based View

3 criteria to document PTL(20-37w)

1-Regular uterine contractions occur at 4/20 min. or 8/60 min. Plus: progressive change in the cervix.

2- Cervical dilatation > 1 cm 3- Effacement _ 80%.

Diagnosis

American Academy of Pediatrician & ACOG 1997

>

Page 22: Preterm Labor : Evidence Based View

Vaginal U/S+ Fibronectin Test Suspected preterm labor with no

cervical changes :Negative fetal fibronectin + Cervical length > 30 mm the likelihood of delivering in the next week

is less than 1%. Thus most women with a negative test can

safely be sent home without treatment.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 23: Preterm Labor : Evidence Based View

Treatment •Inhibition of labor• Corticosteroid• Antibiotics •Others.

Page 24: Preterm Labor : Evidence Based View

Inhibition Of Labor•Bed rest :DVT•Hydration &sedation• Tocolytics

Page 25: Preterm Labor : Evidence Based View

Most Efforts to Prevent Preterm Labor Not Effective

Until effective strategies are found, efforts should be aimed at preventing newborn complications by :

• Corticosteroids• Antibiotics against group B strep • Avoiding traumatic deliveries. • Delivery in a center with experienced

resuscitation teams and neonatal intensive care

ACOG NEWS RELEASE: November 2002

Page 26: Preterm Labor : Evidence Based View

Incidence of preterm birth in USA, 1981-1999.

National Center for Health Statistics. Goldenberg.. Obstet Gynecol 2002

Page 27: Preterm Labor : Evidence Based View

Hydration• Intravenous hydration does not seem

to be beneficial, even during the period of evaluation soon after admission,

• Women with evidence of dehydration may, however, benefit from the intervention.

Stan et al (Cochrane Review 2000). In: The Cochrane Library, Issue 1 2003. Oxford

Page 28: Preterm Labor : Evidence Based View

Is Tocolysis Better Than No Tocolysis For Preterm Labour?

• It is reasonable not to use tocolytic drugs, as there is no clear evidence that they improve outcome. However, tocolysis should be considered if the few days gained would be put to good use, such as completing a course of corticosteroids, or in utero transfer

RCOG Guideline Grade A recommendation 2002 (Valid:2005)

Page 29: Preterm Labor : Evidence Based View

Tocolytics Most authorities do not

recommend use of tocolytics at or after 34 weeks' .

There is no consensus on a lower gestational age limit for the use of tocolytic agents.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 30: Preterm Labor : Evidence Based View

Choice Of Tocolytic Drug

Nifedipine = EpilateAtosiban= Tractocile

B –Sympathomimetic (Ritodrine)Magnesium sulphateIndomethacin

Page 31: Preterm Labor : Evidence Based View

Choice Of Tocolytic Drug If a tocolytic drug is used, ritodrine no

longer seems the best choice.

Atosiban or nifedipine appear preferable as they have fewer adverse effects and seem to have comparable effectiveness.

RCOG Guideline Grade A recommendation 2002 (Valid:2005)

Page 32: Preterm Labor : Evidence Based View

B -Sympathomimetic Agents.

• Use of beta-agonists should be restricted to the management of preterm labour between 20 and 35 completed weeks, including women with ruptured membranes. (Grade A)

RCOG Guideline Grade A recommendation 1997

Page 33: Preterm Labor : Evidence Based View

• Clinical Green Top Guidelines

Tocolytic Drugs for Women in Preterm Labour (1B)

(Replaces Guideline No.1A Beta-agonists and No.1

Ritodrine) Valid until October 2005 unless otherwise indicated

                                             

Page 34: Preterm Labor : Evidence Based View

B -Sympathomimetic Agents.

• Maternal: pulmonary edema, myocardial ischemia, arrhythmia, and even maternal death.

• Fetal : arrhythmia, cardiac septal hypertrophy , hydrops, pulmonary edema, and cardiac failure. hypoglycemia, periventricular-intraventricular hemorrhage, and fetal and neonatal death. .

Page 35: Preterm Labor : Evidence Based View

Magnesium sulphate is ineffective at delaying birth or preventing preterm birth, and its use is associated with an increased mortality for the infant.

Crowther et al, (Cochrane Review) August 2002. In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.

Magnesium Sulfate

Page 36: Preterm Labor : Evidence Based View

Nitric Oxide DonorsThere is insufficient evidence to

support the routine administration of nitric oxide donors (nitroglycerin )in the treatment of preterm labor.

Duckitt& Thornton , (Cochrane Review) March 2002. In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.

Page 37: Preterm Labor : Evidence Based View

Indomethacin Compared with ritodrine there is

insufficient evidence for any differential effect on delay in delivery, but indomethacin does seem to have fewer maternal adverse effects than the beta-agonists

RCOG Guideline Grade B Recommendation 2002 (Valid:2005)

Page 38: Preterm Labor : Evidence Based View

Indomethacin Fetal risk:Premature closure of the ductus.Renal and cerebral vasoconstriction.Necrotising enterocolitis Common with high dose and

prolonged exposure.

RCOG Guideline Grade B Recommendation 2002 (Valid:2005)

Page 39: Preterm Labor : Evidence Based View

Indomethacin Indomethacin therapy for < 48 hours < 30-32 weeks' gestation)Not > 200mg/day.appears to be a relatively safe and

effective tocolytic agent Goldenberg , Obstetrics &Gynecology 11-2002

Page 40: Preterm Labor : Evidence Based View

Indomethacin Indomethacin can be used as a second-line tocolytic agent in early gestational age preterm labors.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 41: Preterm Labor : Evidence Based View

Indomethacin Indomethacin may be a first-

line tocolytic in:• Associated polyhydramnios : ( to have renal effects of

indomethacin)

Newton eMedicine 2002

Page 42: Preterm Labor : Evidence Based View

Indomethacin Capsule 25mg oral Amp 50mg Rectal Supp 100 mg

Newton eMedicine 2002

50 mg Loading dose

Then 25-50mg /6hs

Page 43: Preterm Labor : Evidence Based View

Atosiban: TractocilAtosiban, a synthetic

peptide, is a competitive antagonist of oxytocin at

uterine oxytocin receptors.

Page 44: Preterm Labor : Evidence Based View

Atosiban: TractocilAtosiban - compared with beta-agonists-

has:Little difference in the effect of these agents on

delayed delivery

Fewer maternal adverse effects than beta-agonists, such as chest pain, palpitations , tachycardia , hypotension , dyspnoea ,vomiting , and headache.

Worldwide Atosiban Vs Beta-agonists Study Group. BJOG 2001;108:133–42( RCT)

Page 45: Preterm Labor : Evidence Based View

NifedipineNifedipine- compared with ritodrine -

has:

Higher delaying of delivery for >48 H.

Lower risk of RDS &Neonatal jundice.

Lower admission to NN ICU

Fewer maternal adverse effectsTsatsaris et al, . Obstet Gynecol 2001;97:840–7. (Meta-analysis)

Page 46: Preterm Labor : Evidence Based View

NifedipineWhen tocolysis is indicated for women in

preterm labor, calcium channel blockers are preferable to other tocolytic agents compared, mainly betamimetics.

Further research should address the effects of different dosage regimens and formulations

King et al, (Cochrane Review) 9-2002. In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.

Page 47: Preterm Labor : Evidence Based View

Nifedipine20mg initial

10-20 mg /4-6 h

Epilate capsule :10mg

Epilate retard Tablet: 20 mg

Tsatsaris et al, . Obstet Gynecol 2001;97:840–7. (Meta-analysis)

Page 48: Preterm Labor : Evidence Based View

Maintenance Tocolysis Is Not Recommended For Routine Practice.

There is insufficient evidence for any firm conclusions about whether or not maintenance tocolytic therapy following threatened preterm labor is worthwhile. Therefore maintenance therapy cannot be recommended for routine practice.

RCOG Guideline Grade A recommendation 2002 (Valid:2005)

Page 49: Preterm Labor : Evidence Based View

CorticosteroidsAntenatal corticosteroids are associated

with a significant reduction in rates of RDS, neonatal death and intraventricular haemorrhage, although the numbers needed to treat increase significantly after 34 weeks' gestation.

RCOG Guidelines : Grade A Recommendation

Page 50: Preterm Labor : Evidence Based View

CorticosteroidsThe optimal treatment-delivery

interval for administration of antenatal corticosteroids is after 24 hours but < 7 days after the start of treatment.

RCOG Guidelines : Grade A Recommendation

Page 51: Preterm Labor : Evidence Based View

CorticosteroidsTwo 12 mg doses of betamethasone

given IM 24 hours apart, Or

Four 6 mg doses of dexamethasone given IM 12 hours apart (I-A).

There is no proof of efficacy for any other regimen.

SOGC Recommendation Jan. 2003

Page 52: Preterm Labor : Evidence Based View

Antibiotics There is no evidence of clear

overall benefit from prophylactic antibiotics for preterm labour with intact membranes on neonatal outcomes.

King & Flenady (Cochrane Review August 2002). In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.

Page 53: Preterm Labor : Evidence Based View

Screening for GB Strep.ACOG Advises Screening All Pregnant Women for Group B Strep. ACOG NEWS RELEASE November 2002

Page 54: Preterm Labor : Evidence Based View

Group B Streptococci (GBS) Prophylaxis

All patients in preterm labor are considered at high risk for neonatal GBS sepsis and should receive prophylactic antibiotics regardless of culture status.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 55: Preterm Labor : Evidence Based View

Group B Streptococci (GBS) Prophylaxis

The goal of this strategy is to prevent neonatal sepsis, and not to prevent preterm birth.

Goldenberg , Obstetrics &Gynecology 11-2002

Page 56: Preterm Labor : Evidence Based View

Prophylactic Vitamin K Or Phenobarbital

Have not been shown to significantly prevent periventricular haemorrhages in preterm infants.

Goldenberg , May 2003

Crowther & Henderson-Smart (Cochrane Review May 2003 ) In:The Cochrane Library, Issue 1 2003. Oxford: Update Software

Crowther & Henderson-Smart (Cochrane Review Novemb. 2000 ) In:The Cochrane Library, Issue 1 2003. Oxford: Update Software

Page 57: Preterm Labor : Evidence Based View

ConclusionsVarious strategies that have been used to prevent or treat preterm labor, haven't proven effective.

Tocolysis should be considered only for 2 days- if needed - for corticosteroids thereby , or in utero transfer to a tertiary center .

Page 58: Preterm Labor : Evidence Based View

ConclusionsIf a tocolytic drug is used, ritodrine no longer seems the best choice.

Page 59: Preterm Labor : Evidence Based View

ConclusionsOther drugs with fewer adverse effects and

comparable effectiveness are now recommended

Atosiban or nifedipine have been recommended by RCOG

endomethacin may be used as a 2nd line tocolytic or if there is polyhydramnous

Page 60: Preterm Labor : Evidence Based View

ConclusionsMaintenance tocolytic therapy has no proven effect.

It cannot be recommended for routine practice.

Page 61: Preterm Labor : Evidence Based View

Thank You